Daily
250 words
8/10
Rating

6 August 2026

Hexavalent vaccine in Universal Immunisation Programme

The hexavalent vaccine is a significant component of the Universal Immunisation Programme, a flagship government health policy directly relevant to GS2 syllabus topics on social sector services and welfare schemes.

1 min read Day 2 of 2 1 questions 1 prelims

Notes

  • The Union Health Ministry, in collaboration with the George Institute for Global Health India, the Gates Foundation, Gavi, and John Snow India Private Limited, conducted a study on the hexavalent vaccine.
  • The hexavalent vaccine is a six-in-one combination protecting against diphtheria, tetanus, pertussis, Hepatitis B, polio, and Haemophilus influenzae type b (Hib).
  • Benefits identified include improved efficiency of the Universal Immunisation Programme (UIP), reduced workload for frontline health workers, lower cold-chain requirements, and time savings for caregivers.
  • The vaccine is administered via a single injection.

Part of a longer story

This is day 2 of 2 in Hexavalent vaccine implementation in Universal Immunisation Programme, which has been running since 5 August 2026. Reading it whole is usually worth more than reading today alone — the exam asks how something developed.

Questions

  1. Discuss the potential impact of introducing hexavalent vaccines into the Universal Immunisation Programme on public health delivery and healthcare infrastructure in India. 150 words
    Attempt this — 150 words in 8 min
    0 / 150 words 8:00

Prelims

  1. The hexavalent vaccine, recently studied for inclusion in the Universal Immunisation Programme, provides protection against which of the following diseases?